The DESKTOPIII trial in platinum-sensitive ovarian cancer

Bookmark and Share
Published: 24 Jan 2018
Views: 1049
Prof Sean Kehoe - University of Birmingham, Birmingham, UK

Prof Kehoe speaks with ecancer at the 10th BGICC in Cairo about the DESKTOPIII trial comparing the efficacy of additional tumour debulking surgery versus chemotherapy alone for recurrent platinum-sensitive ovarian cancer.

With survival endpoints not yet reached, he describes the improved survival and quality of life seen in the trial as encouraging for relapsed patients.

Prof Kehoe also discussed the fallopian tube as a site of primary lesions here.